CHICAGO (Reuters) - A new independent analysis shows similar risks of blood clots in patients receiving Johnson & Johnson’s Cypher stent and Boston Scientific Corp.'s Taxus stent, Boston Scientific said late on Monday.>>> Discuss This Story
CHICAGO (Reuters) - A new independent analysis shows similar risks of blood clots in patients receiving Johnson & Johnson’s Cypher stent and Boston Scientific Corp.'s Taxus stent, Boston Scientific said late on Monday.>>> Discuss This Story
